Phosphodiesterase 3B (PDE3B), known to play an important role in acute insulin and cAMP-mediated regulation of lipid metabolism, and PDE4 are the main PDE types expressed in adipocytes. Here we show that members of all PDE4 isoforms are expressed in 3T3-L1 and primary mouse adipocytes. Long-term treatment of 3T3-L1 adipocytes with insulin induced up-regulation of PDE3B and PDE4D in a phosphatidylinositol 3-kinase-dependent manner whereas long-term treatment with β-adrenergic agonists induced down-regulation of PDE3B and up-regulation of PDE4D. Thus, PDE3B and PDE4D can be added to the list of genes regulated by insulin and cAMP-increasing hormones. Altered expression of PDE3B and PDE4D in response to long-term treatment with insulin and catecholamines may contribute to altered regulation of metabolism in diabetes.
Introduction
Cyclic nucleotide phosphodiesterases (PDEs) regulate crucial cellular signalling pathways through hydrolysis of key second messengers, cAMP and cGMP. Eleven PDE families (PDE1-11) have been identified based on their substrate affinities, biochemical and physical properties, mechanisms whereby they are regulated and different sensitivities to inhibitors [1, 2] . Adipocytes express membrane-bound PDE3B and membrane bound as well as cytosolic PDE4s [3] . Insulin and cAMP-mediated activation of PDE3B has been shown to play an important role in the regulation of lipolysis, lipogenesis and glucose uptake in adipocytes [4] [5] [6] . Mechanisms for short-term regulation of PDE3B by insulin have been extensively studied and involve phosphatidylinositol 3-kinase (PI3K)-dependent phosphorylation and activation of the enzyme catalyzed by protein kinase B [7] . Mechanisms for short-term regulation of PDE3B by cAMP may involve protein kinase A, Epacs (Exchange proteins directly activated by cAMP) and PKB [4] [5] [6] .
Less has been elucidated regarding long-term regulation of adipocyte PDE3B. Two promoter regions of PDE3B have recently been characterized and cAMP response element (CRE) binding protein (CREB) appeared to play an important role in mediating up-regulation of PDE3B during differentiation of pre-adipocytes into mature adipocytes [8] . Further, PDE3B has been shown to be down-regulated in adipocytes from obese, insulin resistant cp rats [9] , diabetic, obese KKAy mice [10] and obese db/ db mice [11] .
Interestingly, peroxisome proliferator-activated receptor γ (PPARγ) agonists, used as insulin-sensitizing drugs, were able to restore PDE3B levels [10] [11] [12] . With regard to possible mediators of PDE3B down-regulation, it has been demonstrated that prolonged treatment of 3T3-L1 adipocytes with TNF-α, a cytokine which is up-regulated in obese/diabetic conditions, and ceramide, a suggested mediator of TNF-α action [13] , caused down-regulation of PDE3B [14, 15] . These effects were reversed in the presence of troglitazone (PPARγ-agonist) [15] . Down-regulation of PDE3B in 3T3-L1 adipocytes has also been observed after long-term treatment with dbcAMP, dexamethazone and triiodothyronin [16] .
Very little is known about roles and acute as well as long-term regulation of different PDE4 isoforms (PDE4A, B, C, D, long and short variants, respectively [17] ) in adipocytes. In other cell types, regulation of PDE4 has been shown to occur at the level of phosphorylation, protein interactions and proteolysis [18] .
In this study, we have investigated long-term regulation of adipocyte PDEs under diabetic conditions, mimicked by prolonged exposition of 3T3-L1 adipocytes to high levels of glucose, insulin and β-adrenergic agonists.
Materials and methods
Materials. 3T3-L1 cells were from American Type Culture Collection (Manassas, VA). Dulbecco´s modified Eagle´s medium (DMEM), Penicillin/ Streptomycin (P/S) and foetal calf serum (FCS) were from Gibco BRL. The β3-adrenergic receptor agonist CL 316243 and 3-isobutyl-1-methylxantine (IBMX) were from Sigma. The PDE4 inhibitor, RO 20-1724 was from Biomol and the PDE3 inhibitor, OPC 3911, was a kind gift from Otsuka Pharmaceuticals, Tokyo, Japan.
Cell culture and preparation of adipocyte homogenates. 3T3-L1 fibroblasts (80,000-100,000 per 100 mm plate) were cultured in 10 ml of DMEM containing 10% FCS and 1% P/S at 37 °C under humidified atmosphere (air/CO 2 -19:1). Confluent cells were differentiated for 2 days in DMEM supplemented with 0.5 mM IBMX, 10 µg/ml insulin and 1 µM dexamethasone. Experiments were performed with 3T3-L1 adipocytes (80-95% differentiated) 8-14 days after the initiation of differentiation. Adipocytes were washed and homogenized at 4°C in 300 µl of homogenization buffer (25 mM Tris/HCl, pH 7.5, 250 mM sucrose, 5 mM MgCl 2 , 0.2 mM EGTA, 20 mM β-glycerophosphate, 20 mM phenylphosphate, 1 µg/ml of pepstatin A, 10 µg/ml of antipain and leupeptin).
Homogenates were centrifuged (33000xg) for 45 min at 4°C and the fractions (cytosols and membranes rehomogenized in 300 µl of the homogenization buffer) were collected.
SDS-page and western blot analysis. Samples containing twenty (membrane fraction) and thirty (cytosolic fraction) micrograms of protein measured according to [19] were subjected to polyacrylamide gel electrophoresis (PAGE) (10% acrylamide) and western blot analysis. Polyvinylidene difluoride membranes (Millipore) were blocked for 30 min with 5% milk in TBS-T buffer (50 mM Tris pH 7.5, 150 mM NaCl, 0.1% (w/v) , and incubated overnight with either a 1: 1000 dilution of anti-PDE3B antibodies (raised in rabbits as described in [20] ), or a 1: 5000 dilution of anti-PDE4A, B, PDE activity measurements. PDE3 activity was measured as described previously [21] in the presence or absence of 3 µM OPC 3911 (PDE3 inhibitor) or 10 µM RO 20- 
Results

Long-term treatment of 3T3-L1 adipocytes with insulin results in up-regulation of PDE3B and PDE4D
It has previously been shown that adipocytes express a 135 kDa membrane-bound PDE3B [22] . PDE4 is also known to be expressed in this cell type [3] , however very little is known with regard to the expression pattern of adipocyte PDE4 isoforms. As shown in As shown in Fig. 2A , long-term treatment of 3T3-L1 adipocytes with insulin resulted in increased PDE3B activity in the membrane fraction (1.3-fold and 2.2-fold, after 24 and 46 hours respectively). Up-regulation of PDE3B activity was associated with increased amount of PDE3B protein (Fig. 2B ). PDE3B protein was up-regulated 2-fold after 24 hours and 4-fold after 46 hours of exposition to insulin.
Prolonged treatment of 3T3-L1 adipocytes with insulin caused an increase in PDE4 activity in cytosols from 3T3-L1 adipocytes (2-fold after 24 hours and 1.5-fold after 46 hours) (Fig. 2C ). This increase in activity was associated with increased amount of PDE4D protein (Fig. 2D) . PDE4D protein was up-regulated almost 5-fold after 24 hours and 2-fold after 46 hours of insulin treatment. No alterations in PDE4 A, B or C expression was detected (data not shown).
Inhibition of PI3K abolishes insulin-induced up-regulation of PDE3B and PDE4D
As shown in Fig. 3A , incubation of 3T3-L1 adipocytes with insulin in the presence of the PI3K inhibitor, LY 294002, for 46 hours, resulted in a 60% decrease in insulin-induced PDE3B activity. Furthermore, exposition of the cells to LY 294002 alone resulted in a slightly decreased basal PDE3 activity and a lowering of the PDE3B expression by 35% (Fig. 3B) .
Incubation of 3T3-L1 adipocytes with insulin in the presence of LY 294002 for 24 hours, entirely prevented insulin-induced increase in PDE4 activity and reduced protein expression by 60% (Fig. 3C, D) . The basal PDE4 activity and protein expression was lowered by 10 and 6 %, respectively in comparison to untreated cells (Fig 3D) .
Long-term treatment of 3T3-L1 adipocytes with β-adrenergic receptor agonists induces down-regulation of PDE3B and up-regulation of PDE4D
As shown in Fig. 4A , 46 hour-treatment of 3T3-L1 adipocytes with isoproterenol, a general β-adrenergic receptor agonist or CL316243, a β3AR-specific agonist, caused a decrease in PDE3B activity which was associated with reduced PDE3B protein expression as compared to the control cells (Fig. 4B) . Thus, PDE3 activity was reduced by 30% after a 2 hour-treatment with isoproterenol and this effect was maintained for at least 46 hours (Fig. 4B) . Reduced PDE3B protein expression was observed after 2 and 46 hours of isoproterenol treatment (40% reduction after 46h). Furthermore, stimulation of 3T3-L1 adipocytes with CL 316243 caused a 40% decrease in PDE3B activity after a 2 hour-treatment which was also associated with decreased PDE3B protein expression.
Long-term β-adrenergic receptor stimulation had the opposite, stimulatory effects on PDE4 activity and PDE4D protein expression. After 3 hours, isoproterenol and CL 316243 stimulation increased PDE4 activity 1.5-fold and 1.6-fold whereas after 24 hours PDE4 activity was increased 2-fold and 1.4-fold, respectively (Fig. 4C) . Increased PDE4 activity was associated with increased expression of PDE4D protein, 2-fold after 24 hours, as shown in Fig. 4D . No changes were observed with regard to the expression of PDE4A, B, C (data not shown).
Discussion
New findings regarding long-term regulation of PDE3 and PDE4 in 3T3-L1 adipocytes treated with insulin and β-adrenergic agonists are presented in this study. Thus, insulin induced up-regulation of PDE3B as well as PDE4D, whereas β-adrenergic agonists induced down-regulation of PDE3B and up-regulation of PDE4D. As for other PDE4 isoforms (PDE4A, B, C) also expressed in adipocytes, no hormone-induced alterations in gene expression were observed. Hence, PDE3B and PDE4D can be added to the list of genes regulated by both insulin and cAMP-increasing hormones. Obviously, long-term treatment of cells with insulin and catecholamines alters the expression of many genes regulating energy homeostasis and metabolism, and the exact contribution of altered expression of PDE3B and PDE4D in this context is not known. However, it is known that PDE3B knockout mice show a number of derangements in energy homeostasis, including insulin resistance [7] . As for PDE4, down-regulation of PDE4A appeared to contribute to increased catecholamine sensitivity in adipocytes and to the lean phenotype of mice overexpressing the FOXC2 transcription factor in adipocytes [23] . Thus, altered expression of PDE3B and PDE4 may very well significantly contribute to altered regulation of metabolism.
Insulin-induced up-regulation of PDE3B was found to be PI3K-dependent. [24] . This is interesting in the context of this work, since it has recently been demonstrated that CREB is involved in mediating PDE3B expression during differentiation of 3T3-L1 adipocytes induced by insulin, dbcAMP and dexamethasone [8] .
Whereas in this study long-term treatment with high insulin induced up-regulation of PDE3B activity and protein, PDE3B protein has previously been shown to be downregulated in adipose tissue/ adipocytes of several models of diabetes and obesity [9] [10] [11] .
Therefore, based on the findings from this study, one can conclude that hyperinsulinemia per se does not contribute to the down-regulation of PDE3B observed in vivo. The situation is obviously very complex in the in vivo models where adipocytes are exposed to and differentially affected by an altered environment characterized by a combination of hyperinsulinemia, hyperglycemia, increased fatty acids, increased levels of catecholamines and altered levels of circulating cytokines and other factors [25, 26] . With regard to some of theses conditions one should note that 3T3-L1 adipocytes were cultured in high glucose (25 mM); lowering glucose to 5 mM was associated with a reduction in the effect of insulin on PDE3B gene expression (data not shown), indicating a positive cross-talk between glucose and insulin in increasing PDE3B gene expression.
Increasing the level of oleic acid up to 2 mM for more than 48 hours did not alter PDE3B gene expression in 3T3-L1 adipocytes (data not shown). However, as discussed below, β-adrenergic agonists indeed reduced PDE3B gene expression, in agreement with a previous study showing that dbcAMP reduced PDE3B gene expression in 3T3-L1 adipocytes [14] . Therefore, increased levels of catecholamines in vivo possibly contribute to the down-regulation of PDE3B observed in animal models of diabetes and obesity. Also TNFα which has been shown to reduce PDE3B gene expression in mouse 3T3-L1 cells and in human adipocytes after differentiation from preadipocytes [14] could contribute to the down-regulation of PDE3B observed in the in vivo models.
Mechanisms whereby β-adrenergic receptor agonists cause down-regulation of PDE3B are not known. CREB, a transcriptional factor mediating effects of cAMP and other signalling molecules, has previously been shown to play a critical role in inducing PDE3B gene expression during differentiation of 3T3-L1 adipocytes in a PKA-dependent manner [8] . One could speculate that sustained down-regulation of PDE3B might be the result of CREB-mediated up-regulation of ICER proteins (inducible cAMP early repressors; members of the CRE modulator family) as it was demonstrated to be the case for PDE3A in cardiomyocytes [27] . ICER proteins function as endogenous inhibitors of gene transcription (including their own) mediated by CREB, by competing with CREB in binding CRE sequences [27] . In the above mentioned study it has been shown that PDE3A expression and activity is significantly down-regulated in human failing hearts and that down-regulation of PDE3A leads to apoptosis due to the induction of ICER.
Thus, an autoregulatory positive feedback mechanism of cardiomyocyte apoptosis has been identified: ICER represses PDE3A gene expression and PDE3A reduction in turn enhances ICER expression due to PKA activation [27] . Whether there is an interplay between PDE3B-CREB-ICER in adipocytes is, however, not yet known.
As is the case for PDE3B, PDE4 activity and protein (PDE4D specifically) also was increased in a PI3K-dependent manner by long-term treatment with insulin. Inhibition of PDE4 but not PDE3 has been shown to be important during the differentiation of preadipocytes to mature adipocytes and PDE4 expression appeared to decrease during the differentiation process [28] . In general, very little is known about the role of PDE4 in adipocytes and particularly little is known about insulin in relation to PDE4s. It has been established that ERK, a kinase belonging to the MAP kinase pathway, which is activated by insulin in adipocytes, can influence PDE4 activity [17] . Thus, ERK acutely induces phosphorylation of several PDE4 isoforms. Phosphorylation of short versions of PDE4B and D results in activation of enzyme activity whereas phosphorylation of long versions of PDE4B, C and D results in their inhibition [17] . The inhibitory effect of ERK is transient, as the increase in cAMP caused by PDE4 inhibition activates PKA, which in turn phosphorylates and activates PDE4s [17] , an example of hormone induced crosstalk between different PDEs which most likely can also occur in our system between PDE3B and PDE4D.
The stimulatory effects of β-adrenergic receptor agonists on PDE4D expression might be mediated by CREB since CRE elements have been identified in the PDE4D promoter [29] . In cells other than adipocytes it has also been shown that prolonged exposition to cAMP-increasing agents results in PDE4D up-regulation. Thus, PDE4D appeared to be variants were selectively induced in synthetic VSMC. These expression patterns appeared to be dependent on histone acetylation status of their promoters [30] .
A number of studies on genetically modified animals and on animal models for obesity/ diabetes show that both PDE3B and PDE4 play important roles in the regulation of energy homeostasis. Thus, altered expression of PDE3B as well as PDE4D in response to long-term treatment with insulin and catecholamines may contribute to altered regulation of metabolism in diabetic states. 
